Jeffrey M. Skredenske
Accomplished expert in biologics (upstream and downstream) and bioconjugation with deep experience in process development, manufacturing, and process validation. Demonstrated success leading cross-functional teams and managing strategic CDMO partnerships to advance monoclonal antibody and antibody-drug conjugate programs through early- and late-phase clinical trials and IND and BLA preparation and submission. Strong background in high-impact project […]